Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Risk factors for multidrug-resistant bacteremia in hospitalized cancer patients with febrile neutropenia: a cohort study.

Rosa RG, Goldani LZ, dos Santos RP.

Am J Infect Control. 2014 Jan;42(1):74-6. doi: 10.1016/j.ajic.2013.06.025. Epub 2013 Nov 8.

PMID:
24210467
2.

Factors associated with hospital length of stay among cancer patients with febrile neutropenia.

Rosa RG, Goldani LZ.

PLoS One. 2014 Oct 6;9(10):e108969. doi: 10.1371/journal.pone.0108969. eCollection 2014.

3.

Clinical factors predicting bacteremia in low-risk febrile neutropenia after anti-cancer chemotherapy.

Ha YE, Song JH, Kang WK, Peck KR, Chung DR, Kang CI, Joung MK, Joo EJ, Shon KM.

Support Care Cancer. 2011 Nov;19(11):1761-7. doi: 10.1007/s00520-010-1017-4. Epub 2010 Oct 8.

PMID:
20931237
4.

Stratifying risk factors for multidrug-resistant pathogens in hospitalized patients coming from the community with pneumonia.

Aliberti S, Di Pasquale M, Zanaboni AM, Cosentini R, Brambilla AM, Seghezzi S, Tarsia P, Mantero M, Blasi F.

Clin Infect Dis. 2012 Feb 15;54(4):470-8. doi: 10.1093/cid/cir840. Epub 2011 Nov 21.

5.

The epidemiology of bacteremia with febrile neutropenia: experience from a single center, 1988-2004.

Paul M, Gafter-Gvili A, Leibovici L, Bishara J, Levy I, Yaniv I, Shalit I, Samra Z, Pitlik S, Konigsberger H, Weinberger M.

Isr Med Assoc J. 2007 Jun;9(6):424-9.

6.

Streptococcus pneumoniae bacteremia in patients with cancer: disease characteristics and outcomes in the era of escalating drug resistance (1998-2002).

Kumashi P, Girgawy E, Tarrand JJ, Rolston KV, Raad II, Safdar A.

Medicine (Baltimore). 2005 Sep;84(5):303-12.

7.
8.

IL-8 predicts pediatric oncology patients with febrile neutropenia at low risk for bacteremia.

Cost CR, Stegner MM, Leonard D, Leavey P.

J Pediatr Hematol Oncol. 2013 Apr;35(3):206-11. doi: 10.1097/MPH.0b013e318281e653.

PMID:
23425997
9.

Bacteraemia due to multidrug-resistant Gram-negative bacilli in cancer patients: risk factors, antibiotic therapy and outcomes.

Gudiol C, Tubau F, Calatayud L, Garcia-Vidal C, Cisnal M, Sánchez-Ortega I, Duarte R, Calvo M, Carratalà J.

J Antimicrob Chemother. 2011 Mar;66(3):657-63. doi: 10.1093/jac/dkq494. Epub 2010 Dec 29.

10.

Bacterial colonization of pressure ulcers: assessment of risk for bloodstream infection and impact on patient outcomes.

Braga IA, Pirett CC, Ribas RM, Gontijo Filho PP, Diogo Filho A.

J Hosp Infect. 2013 Apr;83(4):314-20. doi: 10.1016/j.jhin.2012.11.008. Epub 2013 Jan 10.

PMID:
23313027
11.

Incidence and risk factors for carbapenem- and multidrug-resistant Acinetobacter baumannii bacteremia in hematopoietic stem cell transplantation recipients.

Kim SB, Min YH, Cheong JW, Kim JS, Kim SJ, Ku NS, Jeong SJ, Han SH, Choi JY, Song YG, Kim JM.

Scand J Infect Dis. 2014 Feb;46(2):81-8. doi: 10.3109/00365548.2013.857042. Epub 2013 Dec 11.

PMID:
24325335
12.
13.

Risk index score for bacteremia in febrile neutropenic episodes in children with malignancies.

Spasova MI, Grudeva-Popova JG, Kostyanev SS, Genev ED, Stoyanova AA, Kirina VI, Moumdjiev IN.

J BUON. 2009 Jul-Sep;14(3):411-8.

PMID:
19810131
14.

Bacteria causing bacteremia in pediatric cancer patients presenting with febrile neutropenia--species distribution and susceptibility patterns.

Miedema KG, Winter RH, Ammann RA, Droz S, Spanjaard L, de Bont ES, Kamps WA, van de Wetering MD, Tissing WJ.

Support Care Cancer. 2013 Sep;21(9):2417-26. doi: 10.1007/s00520-013-1797-4. Epub 2013 Apr 12.

PMID:
23579946
15.

Totally implantable central venous access port infections in patients with digestive cancer: incidence and risk factors.

Touré A, Vanhems P, Lombard-Bohas C, Cassier P, Péré-Vergé D, Souquet JC, Ecochard R, Chambrier C.

Am J Infect Control. 2012 Dec;40(10):935-9. doi: 10.1016/j.ajic.2012.01.024. Epub 2012 May 26.

PMID:
22633131
16.

Antibiotic resistance is associated with longer bacteremic episodes and worse outcome in febrile neutropenic children with cancer.

El-Mahallawy HA, El-Wakil M, Moneer MM, Shalaby L.

Pediatr Blood Cancer. 2011 Aug;57(2):283-8. doi: 10.1002/pbc.22926. Epub 2010 Dec 22.

PMID:
21671364
17.

No association between protein C levels and bacteremia in children with febrile neutropenia.

Kassam A, Chan AK, Dzolganovski B, Constantin J, Ramphal R, Grant R, Sung L.

J Pediatr Hematol Oncol. 2009 Sep;31(9):647-50. doi: 10.1097/MPH.0b013e3181b1ec89.

PMID:
19644401
18.

Recent changes in bacteremia in patients with cancer: a systematic review of epidemiology and antibiotic resistance.

Montassier E, Batard E, Gastinne T, Potel G, de La Cochetière MF.

Eur J Clin Microbiol Infect Dis. 2013 Jul;32(7):841-50. doi: 10.1007/s10096-013-1819-7. Epub 2013 Jan 25. Review.

PMID:
23354675
19.

Antibiotic-resistant Gram-negative bacteremia in pediatric oncology patients--risk factors and outcomes.

Haeusler GM, Mechinaud F, Daley AJ, Starr M, Shann F, Connell TG, Bryant PA, Donath S, Curtis N.

Pediatr Infect Dis J. 2013 Jul;32(7):723-6. doi: 10.1097/INF.0b013e31828aebc8.

PMID:
23838774
20.

Perils of quinolone exposure in cancer patients: breakthrough bacteremia with multidrug-resistant organisms.

Rangaraj G, Granwehr BP, Jiang Y, Hachem R, Raad I.

Cancer. 2010 Feb 15;116(4):967-73. doi: 10.1002/cncr.24812.

Items per page

Supplemental Content

Write to the Help Desk